Literature DB >> 24080309

Elevated and dysregulated bone morphogenic proteins in immune cells of patients with relapsing-remitting multiple sclerosis.

Karin Mausner-Fainberg1, Nataly Urshansky, Keren Regev, Eitan Auriel, Arnon Karni.   

Abstract

The abundance of neural stem cells (NSCs) in multiple sclerosis (MS) lesions with extensive astrogliosis suggests that fate factors of NSCs, such as the bone morphogenic protein (BMP) signaling maybe defective in MS. We found an elevated mRNA expression and protein secretion of BMP-2,4,5 but not of BMP-7. This was primarily in T cells. Cell stimulation with anti-CD3/CD28 antibodies or with IFN-γ induced expression of BMP-2,4,5 mRNA in untreated RR-MS patients, indicating that proinflammatory processes in MS may play a role in the BMP-2,4,5 productions in T cells. These results contribute to the understanding of the negligible extent of neurogenesis and oligodendrogenesis with extensive astrogliogenesis and the failure of adequate tissue repair in MS lesions.
© 2013.

Entities:  

Keywords:  Bone morphogenic protein; Multiple sclerosis; T cells

Mesh:

Substances:

Year:  2013        PMID: 24080309     DOI: 10.1016/j.jneuroim.2013.09.004

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

Review 1.  The role of TGF-β superfamily signaling in neurological disorders.

Authors:  Risa Kashima; Akiko Hata
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2018-01-01       Impact factor: 3.848

2.  Inhibitors of Myelination and Remyelination, Bone Morphogenetic Proteins, are Upregulated in Human Neurological Disease.

Authors:  Judith B Grinspan
Journal:  Neurochem Res       Date:  2020-02-06       Impact factor: 3.996

Review 3.  Extracellular cues influencing oligodendrocyte differentiation and (re)myelination.

Authors:  Natalie A Wheeler; Babette Fuss
Journal:  Exp Neurol       Date:  2016-03-23       Impact factor: 5.330

4.  ELTD1 as a biomarker for multiple sclerosis: Pre-clinical molecular-targeted studies in a mouse experimental autoimmune encephalomyelitis model.

Authors:  Rheal A Towner; Nataliya Smith; Michelle Zalles; Sara Morris; MacKenzie Toliver; Debra Saunders; Megan Lerner; Gaurav Kumar; Robert C Axtell
Journal:  Mult Scler Relat Disord       Date:  2021-01-22       Impact factor: 4.339

5.  Inhibition of the BMP Signaling Pathway Ameliorated Established Clinical Symptoms of Experimental Autoimmune Encephalomyelitis.

Authors:  Herena Eixarch; Laura Calvo-Barreiro; Carme Costa; Gemma Reverter-Vives; Mireia Castillo; Vanessa Gil; José Antonio Del Río; Xavier Montalban; Carmen Espejo
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 6.088

6.  Increased Expression of Ephrins on Immune Cells of Patients with Relapsing Remitting Multiple Sclerosis Affects Oligodendrocyte Differentiation.

Authors:  Maya Golan; Avivit Krivitsky; Karin Mausner-Fainberg; Moshe Benhamou; Ifat Vigiser; Keren Regev; Hadar Kolb; Arnon Karni
Journal:  Int J Mol Sci       Date:  2021-02-22       Impact factor: 5.923

7.  Specific Blockade of Bone Morphogenetic Protein-2/4 Induces Oligodendrogenesis and Remyelination in Demyelinating Disorders.

Authors:  Karin Mausner-Fainberg; Moshe Benhamou; Maya Golan; Nadav Bleich Kimelman; Uri Danon; Ehud Marom; Arnon Karni
Journal:  Neurotherapeutics       Date:  2021-06-22       Impact factor: 6.088

Review 8.  Reevaluation of Pluripotent Cytokine TGF-β3 in Immunity.

Authors:  Toshihiko Komai; Tomohisa Okamura; Mariko Inoue; Kazuhiko Yamamoto; Keishi Fujio
Journal:  Int J Mol Sci       Date:  2018-08-01       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.